ID   ERFE_RAT                Reviewed;         341 AA.
AC   D4AB34;
DT   01-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   24-JUL-2024, entry version 77.
DE   RecName: Full=Erythroferrone {ECO:0000312|RGD:1584688};
DE   AltName: Full=Complement C1q tumor necrosis factor-related protein 15 {ECO:0000312|RGD:1584688};
DE   AltName: Full=Myonectin {ECO:0000303|PubMed:22351773};
DE   Flags: Precursor;
GN   Name=Erfe {ECO:0000312|RGD:1584688};
GN   Synonyms=C1qtnf15, Ctrp15 {ECO:0000303|PubMed:22351773},
GN   Fam132b {ECO:0000312|RGD:1584688};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION.
RX   PubMed=22351773; DOI=10.1074/jbc.m111.336834;
RA   Seldin M.M., Peterson J.M., Byerly M.S., Wei Z., Wong G.W.;
RT   "Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic
RT   lipid homeostasis.";
RL   J. Biol. Chem. 287:11968-11980(2012).
RN   [3]
RP   FUNCTION.
RX   PubMed=24187137; DOI=10.1074/jbc.m113.500736;
RA   Seldin M.M., Lei X., Tan S.Y., Stanson K.P., Wei Z., Wong G.W.;
RT   "Skeletal muscle-derived myonectin activates the mammalian target of
RT   rapamycin (mTOR) pathway to suppress autophagy in liver.";
RL   J. Biol. Chem. 288:36073-36082(2013).
RN   [4]
RP   FUNCTION.
RX   PubMed=30566056; DOI=10.1161/circresaha.118.313777;
RA   Otaka N., Shibata R., Ohashi K., Uemura Y., Kambara T., Enomoto T.,
RA   Ogawa H., Ito M., Kawanishi H., Maruyama S., Joki Y., Fujikawa Y.,
RA   Narita S., Unno K., Kawamoto Y., Murate T., Murohara T., Ouchi N.;
RT   "Myonectin Is an Exercise-Induced Myokine That Protects the Heart From
RT   Ischemia-Reperfusion Injury.";
RL   Circ. Res. 123:1326-1338(2018).
CC   -!- FUNCTION: Iron-regulatory hormone that acts as an erythroid regulator
CC       after hemorrhage: produced by erythroblasts following blood loss and
CC       mediates suppression of hepcidin (HAMP) expression in the liver,
CC       thereby promoting increased iron absorption and mobilization from
CC       stores (By similarity). Promotes lipid uptake into adipocytes and
CC       hepatocytes via transcriptional up-regulation of genes involved in
CC       fatty acid uptake (PubMed:22351773). Inhibits apoptosis and
CC       inflammatory response in cardiomyocytes via promotion of sphingosine-1-
CC       phosphate (S1P) and cAMP-dependent activation of AKT signaling
CC       (PubMed:30566056). Inhibits autophagy induced by nutrient deficiency in
CC       hepatocytes via promoting the phosphorylation of IRS1, AKT, and MTOR,
CC       and thereby subsequent activation of the AKT-MTOR signaling pathway
CC       (PubMed:24187137). Negatively regulates the differentiation of
CC       osteoblasts, potentially via sequestering BMP2, and thereby inhibits
CC       the activation of SMAD signaling (By similarity). The reduction in BMP2
CC       signaling in osteoblasts also results in an increase in expression of
CC       the osteoclastogenesis-promoting factors TNFSF11/RANKL and SOST,
CC       thereby indirectly promotes bone resorption (By similarity).
CC       {ECO:0000250|UniProtKB:Q6PGN1, ECO:0000269|PubMed:22351773,
CC       ECO:0000269|PubMed:24187137, ECO:0000269|PubMed:30566056}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (By similarity). Forms trimer,
CC       hexamers and higher molecular weight oligomers (By similarity). May
CC       form heteromeric complexes with C1QTNF2 and C1QTNF12 and, to a lesser
CC       extent, with C1QTNF5 and C1QTNF10 (By similarity). Interacts with BMP5
CC       and BMP7; the interaction inhibits BMP-induced transcription of HAMP
CC       (By similarity). Interacts with BMP6; the interaction inhibits BMP-
CC       induced transcription of HAMP (By similarity). Interacts with BMP2 (By
CC       similarity). Interacts with heterodimers composed of BMP2 and BMP6 in
CC       vitro, the interaction inhibits the heterodimer binding to its receptor
CC       BMPR1A/ALK3 and thereby suppresses expression of HAMP (By similarity).
CC       {ECO:0000250|UniProtKB:Q6PGN1}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q6PGN1}.
CC       Note=Secreted when glycosylated at Asn-230 and Asn-282 (By similarity).
CC       Hydroxylation promotes secretion (By similarity).
CC       {ECO:0000250|UniProtKB:Q6PGN1}.
CC   -!- PTM: N-glycosylated; required for secretion of the mature protein.
CC       {ECO:0000250|UniProtKB:Q6PGN1}.
CC   -!- SIMILARITY: Belongs to the adipolin/erythroferrone family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH473997; EDL92028.1; -; Genomic_DNA.
DR   RefSeq; XP_001060107.2; XM_001060107.5.
DR   RefSeq; XP_003754598.1; XM_003754550.4.
DR   AlphaFoldDB; D4AB34; -.
DR   STRING; 10116.ENSRNOP00000045074; -.
DR   GlyCosmos; D4AB34; 4 sites, No reported glycans.
DR   GlyGen; D4AB34; 4 sites.
DR   PhosphoSitePlus; D4AB34; -.
DR   PaxDb; 10116-ENSRNOP00000045074; -.
DR   Ensembl; ENSRNOT00000051810.4; ENSRNOP00000045074.2; ENSRNOG00000024688.5.
DR   Ensembl; ENSRNOT00055015991; ENSRNOP00055012830; ENSRNOG00055009467.
DR   Ensembl; ENSRNOT00060014350; ENSRNOP00060011022; ENSRNOG00060008604.
DR   Ensembl; ENSRNOT00065035938; ENSRNOP00065028976; ENSRNOG00065021144.
DR   UCSC; RGD:1584688; rat.
DR   AGR; RGD:1584688; -.
DR   RGD; 1584688; Erfe.
DR   eggNOG; ENOG502RNS4; Eukaryota.
DR   GeneTree; ENSGT00940000162100; -.
DR   HOGENOM; CLU_057344_1_1_1; -.
DR   InParanoid; D4AB34; -.
DR   OMA; MGQWASV; -.
DR   OrthoDB; 2917198at2759; -.
DR   PhylomeDB; D4AB34; -.
DR   TreeFam; TF331282; -.
DR   PRO; PR:D4AB34; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Proteomes; UP000234681; Chromosome 9.
DR   Bgee; ENSRNOG00000024688; Expressed in skeletal muscle tissue and 7 other cell types or tissues.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0005179; F:hormone activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0015908; P:fatty acid transport; ISO:RGD.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; IBA:GO_Central.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; ISS:UniProtKB.
DR   GO; GO:2000193; P:positive regulation of fatty acid transport; ISO:RGD.
DR   GO; GO:0046326; P:positive regulation of glucose import; IBA:GO_Central.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IMP:UniProtKB.
DR   GO; GO:0019217; P:regulation of fatty acid metabolic process; ISO:RGD.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR052136; Adipolin/Erythroferrone-rel.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   PANTHER; PTHR24019; ADIPOLIN; 1.
DR   PANTHER; PTHR24019:SF11; ERYTHROFERRONE; 1.
DR   SUPFAM; SSF49842; TNF-like; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   3: Inferred from homology;
KW   Disulfide bond; Glycoprotein; Hormone; Hydroxylation; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..341
FT                   /note="Erythroferrone"
FT                   /id="PRO_0000422122"
FT   DOMAIN          186..341
FT                   /note="C1q"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00368"
FT   REGION          30..65
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          78..115
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          137..165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        43..57
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        100..115
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        145..165
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            320
FT                   /note="Required for correct protein folding in the
FT                   endoplasmic reticulum"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1"
FT   MOD_RES         101
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1"
FT   MOD_RES         103
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1"
FT   MOD_RES         104
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1"
FT   MOD_RES         106
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1"
FT   MOD_RES         107
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1"
FT   MOD_RES         109
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1"
FT   CARBOHYD        230
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1, ECO:0000255"
FT   CARBOHYD        282
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PGN1, ECO:0000255"
FT   CARBOHYD        293
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        320
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   341 AA;  36369 MW;  9467635C8DEFDBBD CRC64;
     MASTRSPGGA RTLLACASLL AAMGLGVPES AEPVGTQARP QPPGTELPAP PAHSPPEPTI
     AHAHSVDPRD AWMLFVKQSD KGINSKKRSR TKARRLKLGL PGPPGPPGPQ GPPGPFIPSE
     VLLKEFQLLL KGAVRQREST EHCTRDLTTP ASGGPSRDPV TQELESQDQG AVLALLAATL
     AQSPRAPRVE AAFHCRLRRD VQVERRALHE LGVYYLPEVE GAFRRGPGLN LTSGQYTAPV
     AGFYALAATL HVALTKQPRK GPPQPRDRLR LLICIQSLCQ HNASLETVMG LENSSELFTI
     SVNGVLYLQT GHYTSVFLDN ASGSSLTVRG GSHFSAILLG L
//
